MEDINAVI AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.6 EUR | 0.00% |
|
-1.75% | -6.67% |
| 2022 | MediNavi AG acquired Nordic Swan Pharma Group ApS for Ç69.3 million. | CI |
| 2013 | MediNavi AG announced that it has received funding. | CI |
More news
| 1 week | -1.75% | ||
| 1 month | -1.75% | ||
| 3 months | -6.67% | ||
| 6 months | -6.67% | ||
| Current year | -6.67% |
1 week
5.60
5.60
1 month
5.605.70
Current year
5.606.00
1 year
5.607.00
3 years
2.507.20
5 years
1.807.20
10 years
1.8039.00
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Mertz
CEO | Chief Executive Officer | - | - |
Anna Wohlthat
CEO | Chief Executive Officer | - | - |
Stefan Berg
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sascha Magsamen
CHM | Chairman | 49 | 12-06-25 |
Brian Mertz
CEO | Chief Executive Officer | - | - |
| Director/Board Member | - | - |
Medinavi AG is a Germany-based company holding company of its wholly-owned MediKompass GmbH, which is the Company's operating subsidiary. MediKompass GmbH operates an Online reverse auction platform in the field of medicine and healthcare. It operates four websites: www.medikompass.de, www.zahngebot.de, www.schoenheitsgebot.de and www.tierartzkosten.de. Those websites enable exchange of services, where doctors have access to patients and patients can choose offers for their conditions, as well as obtain a second medical opinion. Through its websites, the Company operates on the general health market, dental market and cosmetic surgery market. On March 5, 2012, the Company announced establishment of new subsidiary, DocMatch GmbH.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -6.67% | 569K | |
| +39.75% | 4.18B | |
| +148.03% | 2.28B | |
| +138.10% | 67.89M |
- Stock Market
- Equities
- MDQ Stock
